Swing Aerobics Licensing, Inc.

New York Institute of Technology

Brian Peskin

George E Mavroudis

Edward F Urban

The invention provides a medicament for the treatment of cancer, cardiovascular diseases and/or inflammation. The medicament may be administered orally, parenterally or topically.

Medicament for treatment of cancer, cardiovascular diseases and inflammation

A medicament for the treatment of cancer and other diseases, including cardiovascular diseases, by increasing cellular oxygenation is described wherein a composition of organically grown, chemically unprocessed and unrefined oils is used that provides a ratio of parent omega-6 to parent omega-3 that is greater than 1:1 and preferably within a range from about 1.1:1 to about 5:1. Most preferably, the ratio is about 2.6:1. The medicament may be administered via capsule or liquid form and preferably on a periodic basis, such as daily. In further embodiments, the medicament may be applied in topical ointment form.

Medicament for treatment of cancer and other diseases

A medicament for treatment of cancer or other diseases by increasing cellular oxygenation is described wherein a composition of oils is used that provides a ratio of parent omega 6 to parent omega 3 that is greater than 1:1 and preferably within a range from about 1.1:1 to about 5:1. Most preferably, the ratio is about 2.6:1. The medicament may be administered via capsule or liquid form and preferably on a periodic basis, such as daily. In further embodiments, the medicament may be applied in topical ointment form.

A method for distributing energy in a vehicle having a hybrid electric drive system that includes an internal combustion engine and at least one electric motor which deliver torque to a primary drive shift having at least two drive wheels operatively associated therewith. The method includes the steps of delivering torque from the internal combustion engine and the electric motor to the primary drive shaft to accelerate the vehicle from a stationary position to a predetermined cruising velocity, disengaging the electric motor from the primary drive shaft once the vehicle has accelerate to the cruising velocity to reduce parasitic drag on the system, and delivering torque from the internal combustion engine to the primary drive shaft utilizing the mean horsepower of the internal combustion engine to maintain the vehicle at the cruising velocity.

Growing community of inventors

Houston, TX, United States of America

Brian Peskin